Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study.
Vandenberghe R, Riviere ME, Caputo A, Sovago J, Maguire RP, Farlow M, Marotta G, Sanchez-Valle R, Scheltens P, Ryan JM, Graf A.
Vandenberghe R, et al. Among authors: caputo a.
Alzheimers Dement (N Y). 2016 Dec 23;3(1):10-22. doi: 10.1016/j.trci.2016.12.003. eCollection 2017 Jan.
Alzheimers Dement (N Y). 2016.
PMID: 29067316
Free PMC article.